Sale!

MYH2 Gene Inclusion Body Myopathy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MYH2 gene inclusion body myopathy genetic test is a specialized diagnostic tool used to identify mutations in the MYH2 gene, which are associated with a rare form of muscle disease known as inclusion body myopathy. This condition is characterized by progressive muscle weakness and wasting, particularly affecting the muscles closest to the center of the body. Early and accurate diagnosis through genetic testing is crucial for managing the symptoms and planning appropriate treatment strategies.

Performed at DNA Labs UAE, the test involves analyzing the patient’s DNA to detect specific mutations in the MYH2 gene that are linked to the development of inclusion body myopathy. The process is highly precise, offering individuals and their healthcare providers valuable insights into the genetic underpinnings of the condition.

The cost of the MYH2 gene inclusion body myopathy genetic test at DNA Labs UAE is 4400 AED. While the price may seem high, the test provides essential information for the proper diagnosis and management of the condition, potentially improving the quality of life for those affected. Patients considering this test are advised to consult with their healthcare provider to discuss its benefits and implications fully.

Description

MYH2 Gene Inclusion Body Myopathy Genetic Test

Test Name: MYH2 Gene Inclusion Body Myopathy Genetic Test

Components: MYH2 gene analysis

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MYH2 Gene Inclusion Body Myopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MYH2 Gene Inclusion Body Myopathy.

Test Details: The MYH2 gene is associated with inclusion body myopathy, a rare genetic disorder characterized by muscle weakness and wasting. Inclusion body myopathy can be caused by mutations in the MYH2 gene, which encodes for the myosin heavy chain 2 protein.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can detect mutations or variations in the MYH2 gene and other genes associated with inclusion body myopathy. NGS testing is more efficient and cost-effective compared to traditional sequencing methods, as it can analyze multiple genes in a single test.

The MYH2 gene inclusion body myopathy NGS genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the MYH2 gene. The results of the test can help in confirming a diagnosis of inclusion body myopathy and provide information about the specific genetic variant involved.

Genetic testing can be useful for individuals with symptoms suggestive of inclusion body myopathy, as well as for their family members who may be at risk of inheriting the condition. It can aid in diagnosis, inform treatment decisions, and provide valuable information for genetic counseling and family planning. However, it is important to note that genetic testing may not always provide a definitive diagnosis, and clinical evaluation by a healthcare professional is still necessary.

Test Name	MYH2 Gene Inclusion body myopathy Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for MYH2 Gene Inclusion body myopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MYH2 Gene Inclusion body myopathy
Test Details	The MYH2 gene is associated with inclusion body myopathy, a rare genetic disorder characterized by muscle weakness and wasting. Inclusion body myopathy can be caused by mutations in the MYH2 gene, which encodes for the myosin heavy chain 2 protein. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. It can detect mutations or variations in the MYH2 gene and other genes associated with inclusion body myopathy. NGS testing is more efficient and cost-effective compared to traditional sequencing methods, as it can analyze multiple genes in a single test. The MYH2 gene inclusion body myopathy NGS genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any mutations or variations in the MYH2 gene. The results of the test can help in confirming a diagnosis of inclusion body myopathy and provide information about the specific genetic variant involved. Genetic testing can be useful for individuals with symptoms suggestive of inclusion body myopathy, as well as for their family members who may be at risk of inheriting the condition. It can aid in diagnosis, inform treatment decisions, and provide valuable information for genetic counseling and family planning. However, it is important to note that genetic testing may not always provide a definitive diagnosis, and clinical evaluation by a healthcare professional is still necessary.